Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | BCHE | P06276 | 8/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminopyrine SCHEMBL1331641 | 1.00 | ALOX15 (1.00) | ALOX15LMNACYP1A2THRBTSHR | |
| Aminopyrine SCHEMBL10489978 | 1.00 | ALOX15 (1.00) | ALOX15LMNACYP1A2THRBTSHR | |
| Aminopyrine SCHEMBL2818734 | 0.98 | ALOX15 (0.97) | ALOX15LMNACYP1A2THRBTSHR | |
| Aminopyrine SCHEMBL8723416 | 0.92 | ALOX15 (0.85) | ALOX15LMNACYP1A2THRBTSHR | |
| Aminopyrine SCHEMBL28152267 | 0.92 | ALOX15 (0.85) | ALOX15LMNACYP1A2THRBTSHR | |
| Aminopyrine SCHEMBL10493337 | 0.90 | ALOX15 (0.81) | ALOX15LMNACYP1A2THRBTSHR | |
| Propyphenazone SCHEMBL28086369 | 0.90 | LMNA (0.81) | ALOX15LMNACYP1A2THRBTSHR | |
| Aminopyrine SCHEMBL28086243 | 0.89 | ALOX15 (0.78) | ALOX15LMNACYP1A2THRBTSHR | |
| Aminopyrine SCHEMBL7042293 | 0.84 | ALOX15 (0.71) | ALOX15LMNACYP1A2THRBTSHR | |
| SCHEMBL13243351 | 0.84 | ALOX15 (0.72) | ALOX15LMNACYP1A2THRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9091 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130928-A1 | COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN | ASCENTAWITS PHARMACEUTICALS LTD (CN) | 2026-05-14 | — | — | US | claimed |
| US-20260083666-A1 | METHOD OF TREATING DISEASE | CREWS THOMAS M (US) | 2026-03-26 | — | — | US | claimed |
| US-20260069532-A1 | METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE | MEDINCELL S.A. (FR) | 2026-03-12 | — | — | US | claimed |
| US-12558309-B2 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | MEDINCELL S.A. (FR) | 2026-02-24 | — | — | US | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-3480730-B1 | 3D ANISOTROPIC HYBRID NETWORK: TRANSFERRING CONVOLUTIONAL FEATURES FROM 2D IMAGES TO 3D ANISOTROPIC VOLUMES | Siemens Healthineers Ag (DE) | 2025-11-26 | — | — | EP | claimed |
| WO-2025224317-A1 | A METHOD FOR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLE IN TOTAL KNEE REPLACEMENT | MEDINCELL S.A. (FR) | 2025-10-30 | — | — | WO | claimed |
| EP-4630574-A1 | TEST SYSTEM FOR MEASURING THE ENZYME ACTIVITY OF ANGIOTENSIN-CONVERTING ENZYME (ACE) | DiaSys Diagnostic Systems GmbH (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-4182532-B1 | FURNITURE FITTING FOR MOUNTING A FURNITURE PART | BLUM GMBH JULIUS (AT) | 2025-09-24 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| EP-0311616-A4 | COMBINATIONS OF GAMMA INTERFERONS AND ANTI-INFLAMMATORY OR ANTI-PYRETIC AGENTS FOR TREATING DISEASES. | BIOGEN NV (NL) | 1989-05-23 | — | — | EP | claimed |
| EP-0311616-A1 | COMBINATIONS OF GAMMA INTERFERONS AND ANTI-INFLAMMATORY OR ANTI-PYRETIC AGENTS FOR TREATING DISEASES. | BIOGEN NV (NL) | 1989-04-19 | — | — | EP | claimed |
| US-4757016-A | Adding aminopyrine as stabilizer | BOEHRINGER MANNHEIM GMBH (DE) | 1988-07-12 | — | — | US | claimed |
| WO-1987007842-A1 | COMBINATIONS OF GAMMA INTERFERONS AND ANTI-INFLAMMATORY OR ANTI-PYRETIC AGENTS AND METHODS FOR TREATING DISEASES | BIOGEN N.V. (AN) | 1987-12-30 | — | — | WO | claimed |
| EP-0147780-A2 | Drug delivery device | MERCK & CO. INC. (US) | 1985-07-10 | — | — | EP | claimed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | claimed |
| EP-0129893-A2 | Ground mixture | Takeda Chemical Industries, Ltd. (JP) | 1985-01-02 | — | — | EP | claimed |
| US-4420476-A | Benzofuro[3,2-c]pyrazol-3-amine derivatives | Averst McKenna & Harrison, Inc. (CA) | 1983-12-13 | — | — | US | claimed |
| US-4350762-A | BLOCKING INTERFERENCE BY BILITRUBIN | ELVI S.P.A. (IT) | 1982-09-21 | — | — | US | claimed |
| EP-0033462-A1 | Aminopyrine improved Trinder's reagent and dosing process for hydrogen peroxide from enzimatic oxidation of metabolic substrata with the same | ELVI S.p.A. (IT) | 1981-08-12 | — | — | EP | claimed |